Mid-market investor Ergon has held the final closing of Ergon Capital Partners IV, SCSP (ECP IV) with capital commitments in excess of EUR580 million.
Based on strong demand from investors, ECP IV significantly exceeded its target of EUR500 million. ECP IV, Ergon’s first institutional fundraise, attracted both existing and new investors to the platform, with investors from the Benelux, France, Germany and Switzerland well represented in the Fund. The investor base includes blue-chip financial institutions, asset managers, funds of funds, family offices and foundations among others, alongside Sienna Capital, the fully-owned subsidiary of Groupe Bruxelles Lambert, who remained as cornerstone investor. All existing investors successfully re-upped into the Fund.
Wolfgang de Limburg, Managing Partner of Ergon, says: “We are delighted to have had so many high-quality investors show their trust in our team and strategy. Ergon’s development over the past few years, including the growth of the platform and the institutionalisation of the firm, resulted in a highly successful fundraise.”
“Ergon’s differentiated positioning as a pan-European mid-market player and its reputation as a partner of choice to families, entrepreneurs and managers ensure that it is well-positioned to take advantage of the opportunity set. Our core markets continue to generate strong deal flow,” added Emanuele Lembo, Managing Partner of Ergon.
ECP IV will continue Ergon’s successful strategy of making buyout investments in attractive mid- market companies primarily in the niche industrials, healthcare, retail/consumer goods/luxury and media, services & leisure sectors, located in the Benelux, France, Germany, Italy and Iberia. The Ergon team will retain its focus on making disciplined, responsible and discreet value investments with a long-term horizon to create value through professionalisation, operational improvement and growth acceleration.
Houlihan Lokey Private Funds Group (formerly BearTooth Advisors) led the fundraise as a global advisor to Ergon, with Evercore Private Capital Advisory acting as independent advisor. Kirkland & Ellis LLP and Arendt & Medernach acted as legal counsels.
